Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113249417B reveals a biocatalytic route for chiral cis-beta-aryl-beta-hydroxy-alpha-amino esters using KRED-Bt, offering high stereoselectivity and industrial scalability.
Patent CN108359649A reveals high-selectivity alcohol dehydrogenase mutants for synthesizing chiral biaryl alcohols, offering cost reduction and supply reliability.
Patent CN118909993A reveals a high-activity imine reductase mutant for green synthesis. Achieves >99% optical purity and high space-time yield for reliable supply.
Patent CN105063163A reveals enzyme-catalyzed DKR for high-purity chiral intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN101613666B details a novel Bacillus sp. ECU0015 strain for high-purity chiral diol production, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN101709323B reveals a novel biocatalytic coupling method for R-mandelic acid production, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN116199591A reveals high-purity levocarnitine synthesis via whole-cell catalysis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN117210431A reveals thermostable transaminase mutant for high-purity L-glufosinate. Achieves cost reduction in agrochemical manufacturing and supply reliability.
Advanced enzymatic deracemization of L-glufosinate-ammonium via patent CN112410383B. Delivers superior purity and cost efficiency for global agrochemical supply chains.
Patent CN109797174B reveals high-yield ketoreductase route. Reduces heavy metal waste, ensures 100% ee. Ideal for veterinary API supply chains.
Novel enzymatic synthesis of ritodrine hydrochloride ensures high purity and cost efficiency for pharmaceutical supply chains globally seeking reliable manufacturing partners.
Patent CN117070577A reveals dual-enzyme cascade for high-purity L-glufosinate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN115109759B reveals novel LsCR mutants for chiral alcohol synthesis. Achieve superior stability and yield for reliable pharmaceutical intermediate supply chains.
Novel biocatalytic route for Hydroxytyrosol using polyphenol oxidase and ascorbic acid inhibition ensures high purity and scalable production for pharmaceutical intermediates.
Patent CN107119084B details a dual-enzyme process for high-purity L-glufosinate-ammonium. This method offers significant cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN107502647B reveals a novel enzymatic deracemization route for L-glufosinate-ammonium, offering superior optical purity and cost-effective manufacturing for global agrochemical supply chains.
Patent CN111321193B details a novel enzymatic deracemization for high-purity L-glufosinate. Discover cost-effective biocatalytic solutions for herbicide manufacturing.
Patent CN100392090C details a novel enzymatic resolution for L/D-Methionine-15N. Achieve high isotopic abundance and optical purity with scalable biocatalytic processes.
Patent CN101899484B details a novel co-immobilization method for genipin production, offering high purity, extended enzyme stability, and significant cost reductions for supply chains.
Novel enzymatic route for (2S,3R)-p-methylsulfonylphenylserine ethyl ester eliminates copper waste and resolution steps, offering cost-effective API intermediate supply.